March 23, 2023 by Foundation Healthcare Holdings
Partner Valerie Kong led the deal, with support from senior associate Ivan Chan, and associates Victor Leung and John Wu. The core deal team was supported by various teams across the Clifford Chance network, including on financing, antitrust, regulatory and capital markets aspects.
Valerie said, “We are immensely proud to support SeaTown on its investment into FHH. Singapore’s robust healthcare industry continues to be a key sector for investments by financial investors. We wish SeaTown and the FHH management team every success with their partnership.”
Clifford Chance has an extensive portfolio consisting of transactions in healthcare within Asia Pacific. It most recently advised CVC on its acquisition of Xi’an Yikang Pharmacy, Sipai Health Technology’s Hong Kong IPO and Listing, and Prenetics on its acquisition of majority stake in ACT Genomics.
November 14, 2024
Mediacorp CAPITAL 95.8FM Coverage: "多名艺人都曾罹患的甲状腺癌 到底是怎样的疾病?”